v3.25.3
NATURE OF BUSINESS & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 9 Months Ended
Sep. 30, 2025
Accounting Policies [Abstract]  
Schedule of Share Information Related to Common Stock Share information related to the Company’s common stock as of September 30, 2025, is as follows:
Class A Common StockClass B Common StockTotal Common Stock
Authorized210,000,00090,000,000300,000,000
Issued52,763,1341,697,85554,460,989
Outstanding52,566,6501,697,85554,264,505
Schedule of Deferred Revenue Activity The following table represents the deferred revenue activity for the three months ended September 30, 2025:
In ThousandsDeferred Revenue
Balance as of June 30, 2025$918 
Consideration earned(615)
Consideration received629 
Balance as of September 30, 2025$932 


The following table represents the deferred revenue activity for the three months ended September 30, 2024:

In ThousandsDeferred Revenue
Balance as of June 30, 2024$1,623 
Consideration earned(1,667)
Consideration received1,126 
Balance as of September 30, 2024$1,082 

The following table represents the deferred revenue activity for the nine months ended September 30, 2025:

In ThousandsDeferred Revenue
Balance as of December 31, 2024$932 
Consideration earned(2,582)
Consideration received2,582 
Balance as of September 30, 2025$932 

The following table represents the deferred revenue activity for the nine months ended September 30, 2024:

In ThousandsDeferred Revenue
Balance as of December 31, 2023$1,210 
Consideration earned(3,050)
Consideration received2,922 
Balance as of September 30, 2024$1,082 
Schedule of Computation of Basic and Diluted Net Loss Per Share of Class A Common Stock The following table shows the computation of basic and diluted net loss per share of Class A Common Stock for the three and nine months ended September 30, 2025, and 2024:
Three Months Ended September 30,Nine Months Ended September 30,
In Thousands, Except Share and Per Share Amounts2025202420252024
Numerator:
Net loss attributable to Cibus, Inc. stockholders$(23,541)$(179,968)$(95,799)$(228,286)
Denominator:
Weighted average shares of Class A common stock outstanding52,525,77623,536,74640,825,94522,055,979
Effect of pre-funded warrants400,00050,0002,438,64550,000
Weighted average shares of Class A common stock outstanding – basic and diluted52,925,77623,586,74643,264,59022,105,979
Basic and diluted net loss per share of Class A common stock$(0.44)$(7.63)$(2.21)$(10.33)
Schedule of Antidilutive Securities Excluded from Computation of Loss Per Share The following potential dilutive securities, presented on an as converted basis, were excluded from the calculation of net loss per share of Class A Common Stock due to their antidilutive effect:

As of September 30,
20252024
Stock options outstanding1,383,856150,899
Unvested restricted stock units1,566,701115,541
Unvested restricted stock awards115,351392,097
Common warrants10,496,5231,456,523
Total13,562,4312,115,060
Schedule of Segment Financial Information Used by CODM to Assess Segment Performance and Make Decisions
Segment financial information, including significant segment expenses, which are regularly provided to the CODM and included in net loss was as follows:

Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2025202420252024
Revenue$615 $1,667 $2,582 $3,050 
Less:
Personnel expenses6,6417,61420,18922,129
Professional fees1,0272,4979,1589,030
Stock-based compensation1,8862,6876,3638,030
Goodwill impairment—181,43220,950181,432
Other segment expenses (1)
6,4997,87420,87722,801
Total operating expenses16,053202,10477,537243,422
Loss from operations(15,438)(200,437)(74,955)(240,372)
Royalty liability interest expense - related parties(9,030)(8,875)(26,075)(25,953)
Other interest income, net158160383522
Non-operating income, net17,7064178,917
Income tax benefit (expense)6(13)(23)(23)
Total segment loss$(24,303)$(201,459)$(100,253)$(256,909)

_______________________________________
(1) Other segment expenses are primarily comprised of insurance, loss on asset disposal, amortization and depreciation, rent and utilities, lab supplies, product development, and selling and marketing expenses.
Schedules of Concentration of Risk, by Risk Factor

The following table illustrates customer concentration as a percentage of total revenue:

Three Months Ended September 30,Nine Months Ended September 30,
Concentration of revenue greater than 10% of total company revenues2025202420252024
Customer A62.7%86.9%77.4%73.4%
Customer B22.0%8.1%15.6%12.2%
Customer C15.0%5.0%6.7%13.0%


The following table illustrates customer concentration as a percentage of total accounts receivable:

Concentration of accounts receivable greater than 10% of the total accounts receivable balanceSeptember 30, 2025December 31, 2024
Customer A75.1%87.0%
Customer B24.9%13.0%